For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 INDIANAPOLIS, May 29, 2018 — Highly regarded neurosurgeon, Mark Rosenblum, MD, has joined the Board of Directors of Indianapolis-based medical device company, NICO Corporation. Dr. Rosenblum has authored 7 books and more than 250 articles and chapters relating to neurosurgery and neuroscience and has received many awards […]
New Published Evidence for Deadly High-Grade Gliomas Linked to Improved Survival
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 Data shows BrainPath® surgical approach achieves 97 percent average tumor removal INDIANAPOLIS, May 22, 2018 — Patients with the “worst of the worst” kind of brain tumor have new hope today with recent clinical study data on high-grade gliomas (HGG) that shows a new trans-sulcal surgical approach […]
NICO Continues to Innovate with Smallest Trans-Sulcal Brain Access Tool in the World
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 11 mm diameter BrainPath® offers smaller footprint and less displacement of brain tissue NEW ORLEANS, May 1, 2018 — NICO Corporation introduced today the 11 mm diameter BrainPath – the world’s smallest trans-sulcal access system for subcortical surgery – at the America Association of Neurological Surgeons (AANS) […]
NICO Corporation Appoints New Vice President of Sales
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 J&J veteran sales executive tapped to double NICO sales team to advance mission of revolutionizing minimally invasive neurosurgery INDIANAPOLIS, January 18, 2018 — Neurosurgical medical device maker of the world’s first and only trans-sulcal system for standardized subcortical surgery, NICO Corporation, today announced Tim Davis as the […]
Inclusion of NICO BrainPath Approach for Minimal Access Surgery into Pilot ERAS Protocol Supports Possibility for Improved Patient Outcomes
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 BOSTON, October 10, 2017 — The concept of including minimally disruptive technologies by NICO Corporation within a pilot neurosurgical Enhanced Recovery After Surgery (ERAS) protocol was released in a digital poster (#4156) this week at the Congress of Neurological Surgeons (CNS) annual meeting. The observations support the […]
Data on Largest Adult Patient Cohort Shows Diversity, Utility of NICO BrainPath® for Treatment of Tumors, Hemorrhages Located in Deep Subcortical Regions
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 50 papers, posters & abstracts now published with evidence suggesting improved clinical outcomes BOSTON, October 9, 2017 — A late-breaking scientific poster detailing an experiential summary of 1,032 adult patient cases undergoing brain surgery using the NICO BrainPath for accessing and removing deep-seated lesions was released today […]
New Study Reveals Nearly $12,000 per Patient Economic Benefit for Hospitals Using New Technology for Brain Tumor Removal and Stroke Treatment
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 INDIANAPOLIS, August 28, 2017 — A clinically published non-disruptive approach to brain surgery using technologies developed by NICO Corporation has shown a greater than 50 percent average reduction in intensive care unit (ICU) length of stay for appropriate patients with brain tumors and hemorrhagic stroke. The results […]
High Interest in Early Removal of Hemorrhagic Stroke Leads to Doubling Number of Clinical Trial Sites
For Immediate Release Contact: Sue Goin sue.goin@sapphire-com 317.402.8690 Indianapolis, IN, July 27, 2017 —The ENRICH (Early MiNimally-invasive Removal of ICH) randomized clinical trial launched in January this year, designed to compare the outcomes between early intervention of clot removal using the BrainPath Approach™ and the medical management standard of care, has doubled its trial site […]